Anbio Biotechnology Class A Ordinary Shares (NNNN) — Capital Reinvestment Ratio
Anbio Biotechnology Class A Ordinary Shares (NNNN) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow ($1.60 Million) in capital expenditures ($1.67). See Anbio Biotechnology Class A Ordinary Sha (NNNN) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Anbio Biotechnology Class A Ordinary Shares Capital Reinvestment Ratio (2022–2022)
This chart tracks Anbio Biotechnology Class A Ordinary Shares's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Anbio Biotechnology Class A Ordinary Shares (2022–2022)
Year-by-year Capital Reinvestment Ratio for Anbio Biotechnology Class A Ordinary Shares from 2022 to 2022. For live market cap and broader valuation context, see NNNN market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.00x | $4.45 Million | $2.88 | — |